SOXs in human prostate cancer: implication as progression and prognosis factors

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Zhong, Wei de ^a,b,c   Qin, Guo qiang ^a,c   Dai, Qi shan ^a,c   Han, Zhao dong ^a   Chen, Shan ming ^a   Ling, Xiao hui ^a   Fu, Xin ^a   Cai, Chao ^a   Chen, Jia hong ^a   Chen, Xi bin ^a   Lin, Zhuo yuan ^a   Deng, Ye han ^a   Wu, Shu lin ^d   He, Hui chan ^a   Wu, Chin lee ^d  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biochemical recurrence free survival; Clinicopathological feature; Prostate cancer; SOX

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX7; TRANSCRIPTION FACTOR SOX9;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CASTRATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOX10 GENE; SOX7 GENE; SOX9 GENE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MIDDLE AGED; ORCHIECTOMY; PROGNOSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SOX TRANSCRIPTION FACTORS; SOX9 TRANSCRIPTION FACTOR; SOXE TRANSCRIPTION FACTORS; SOXF TRANSCRIPTION FACTORS;

EID: 84862160498     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-248     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Klotz L. Hormone therapy for patients with prostate carcinoma. Cancer 2000, 88:3009-3014. 10.1002/1097-0142(20000615)88:12+<3009::AID-CNCR17>3.0.CO;2-E, 10898345.
3. Hu R, Denmeade SR, Luo J. Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer. Expert Rev Endocrinol Metab. 2010, 5:753-764. 10.1586/eem.10.49, 3035007, 21318111.
4. Eisenberger MA, Blumenstein BA, Crawford ED. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998, 339:1036-1042. 10.1056/NEJM199810083391504, 9761805.
5. Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, Thijssen PE, Wirtz PW, Twijnstra A, Smitt PA, van der Maarel SM, Verschuuren JJ. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 2009, 27:4260-4267. 10.1200/JCO.2008.20.6169, 19667272.
6. Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS One 2008, 3:e2714. 10.1371/journal.pone.0002714, 2444023, 18628953.
7. Wang H, McKnight NC, Zhang T, Lu ML, Balk SP, Yuan X. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res 2007, 67:528-536. 10.1158/0008-5472.CAN-06-1672, 17234760.
8. Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, Balk SP, Yuan X. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 2008, 68:1625-1630. 10.1158/0008-5472.CAN-07-5915, 18339840.
9. Katoh M. Expression of human SOX7 in normal tissues and tumors. Int J Mol Med 2002, 9:363-368.
10. Guo L, Zhong D, Lau S, Liu X, Dong XY, Sun X, Yang VW, Vertino PM, Moreno CS, Varma V, Dong JT, Zhou W. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 2008, 6:1421-1430. 10.1158/1541-7786.MCR-07-2175, 2652859, 18819930.
11. Chen JH, He HC, Jiang FN, Militar J, Ran PY, Qin GQ, Cai C, Chen XB, Zhao J, Mo ZY, Chen YR, Zhu JG. Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in Chinese Population. 2011, In press.
12. Thomsen MK, Ambroisine L, Wynn S, Cheah KS, Foster CS, Fisher G, Berney DM, Møller H, Reuter VE, Scardino P, Cuzick J, Ragavan N, Singh PB, Martin FL, Butler CM, Cooper CS, Swain A, . Transatlantic Prostate Group SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res 2010, 70:979-987. 10.1158/0008-5472.CAN-09-2370, 3083842, 20103652, Transatlantic Prostate Group.
13. Samant GV, Schupp MO, Francois M, Moleri S, Kothinti RK, Chun CZ, Sinha I, Sellars S, Leigh N, Pramanik K, Horswill MA, Remadevi I, Li K, Wilkinson GA, Tabatabai NM, Beltrame M, Koopman P, Ramchandran R. Sox factors transcriptionally regulate ROBO4 gene expression in developing vasculature in zebrafish. J Biol Chem 2011, 286:30740-30747. 10.1074/jbc.M111.220665, 3162435, 21730073.
14. Cui J, Shen X, Zhao H, Nagahama Y. Genome-wide analysis of Sox genes in Medaka (Oryzias latipes) and their expression pattern in embryonic development. Cytogenet Genome Res 2011, 134:283-294. 10.1159/000329480, 21720154.
15. Gracz AD, Magness ST. Sry-box (Sox) transcription factors in gastrointestinal physiology and disease. Am J Physiol Gastrointest Liver Physiol 2011, 300:G503-G515. 10.1152/ajpgi.00489.2010, 3302185, 21292996.
16. Wei L, Cheng D, Li D, Meng M, Peng L, Tang L, Pan M, Xiang Z, Xia Q, Lu C. Identification and characterization of Sox genes in the silkworm, Bombyx mori. Mol Biol Rep 2011, 38:3573-3584. 10.1007/s11033-010-0468-5, 21161409.
17. Harris ML, Baxter LL, Loftus SK, Pavan WJ. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res 2010, 23:496-513. 10.1111/j.1755-148X.2010.00711.x, 2906668, 20444197.
18. Hosking B, Franois M, Wilhelm D, Orsenigo F, Caprini A, Svingen T, Tutt D, Davidson T, Browne C, Dejana E, Koopman P. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development 2009, 136:2385-2391. 10.1242/dev.034827, 19515696.
19. Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, Han Z, Wang X, Ren G, Su D, Huang B, Lu J. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 2009, 277:29-37. 10.1016/j.canlet.2008.11.014, 19108950.
20. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F, Beltrame M. Sox18 and Sox7 play redundant roles in vascular development. Blood 2008, 111:2657-2666. 10.1182/blood-2007-07-100412, 18094332.
21. Tsuchiya M, Ogawa H, Suzuki T, Sugiyama N, Haraguchi T, Hiraoka Y. Exportin 4 Interacts with Sox9 through the HMG Box and Inhibits the DNA Binding of Sox9. PLoS One 2011, 6:e25694. 10.1371/journal.pone.0025694, 3185033, 21991335.
22. Sashikawa Kimura M, Mutoh H, Sugano K. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. 2011, In press.
23. Drivdahl R, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, Plymate SR. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 2004, 23:4584-4593. 10.1038/sj.onc.1207603, 15077158.
24. Pan ZW, Lou J, Luo C, Yu L, Li JC. Association analysis of the SOX10 polymorphism with Hirschsprung disease in the Han Chinese population. J Pediatr Surg 2011, 46:1930-1934. 10.1016/j.jpedsurg.2011.05.017, 22008330.
25. Silva CY, Goldberg LJ, Mahalingam M, Bhawan J, Wolpowitz D. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?. J Cutan Pathol 2011, 38:797-800.
26. Bremer M, Fröb F, Kichko T, Reeh P, Tamm ER, Suter U, Wegner M. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 2011, 59:1022-1032. 10.1002/glia.21173, 21491499.
27. Agnarsdóttir M, Sooman L, Bolander A, Strömberg S, Rexhepaj E, Bergqvist M, Ponten F, Gallagher W, Lennartsson J, Ekman S, Uhlen M, Hedstrand H. SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Res 2010, 20:468-478. 10.1097/CMR.0b013e3283403ccd, 20890226.
28. Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol 2008, 32:1291-1298. 10.1097/PAS.0b013e3181658c14, 18636017.